Search Tag: Aprecia
2023 30 Jan
Aprecia Pharmaceuticals announced Owen Murray as its Chief Executive Officer. Murray will lead the expansion of Aprecia’s offerings in proprietary 3D-Printed pharmaceutical technologies. “Owen has a unique background in both healthcare innovation and pharmaceutical commercialization. His expertise will position Aprecia to further capitalize on...Read more
2015 10 Aug
The U.S. Food and Drug Administration has approved the first 3D-printed drug, SPRITAM ® , for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy. The FDA approval is being hailed as a breakthrough in precision...Read more